Request Sample Inquiry
Pharmaceutical Packaging Market

Pharmaceutical Packaging Market

Pharmaceutical Packaging Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

250

Base Year:

2023

Date

May - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2477

Segments Covered
  • By Type By Type Plastic Bottles, Blister Packs, Caps & Closures, Pre-filled Syringes, Pouches & Strips, Pre-filled Inhalers, Vials, Ampoules, Cartridges, Labels & Accessories, Medical Specialty Bags, Temperature-controlled Packaging, Medication Tubes, Jars & Canisters, Others
  • By Drug Delivery By Drug Delivery Oral Drugs, Pulmonary, Transdermal, Injectables, Topical, Nasal, Ocular/Ophthalmic, IV Drugs, Others
  • By Packaging Type By Packaging Type Primary, Secondary
  • By Raw Material By Raw Material Plastics, Paper & Paperboard, Glass, Metal, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 143 Billion
Revenue 2032Revenue 2032: USD 500 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 15%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Pharmaceutical Packaging Market Share

The global Pharmaceutical Packaging Market is valued at USD 143 Billion in 2023 and is projected to reach a value of USD 500 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 15% between 2024 and 2032.

Key Highlights of Pharmaceutical Packaging Market

  • North America predominantly led the Pharmaceutical Packaging market in 2023, with 36.5% of the total market share
  • Asia Pacific is anticipated to register the fastest growth from 2024 to 2032
  • The Plastic Bottles segment majorly contributed to the market’s expansion, constituting over 24.4% revenue share in 2023
  • The Oral Drugs segment played a significant role in driving the market’s growth in 2023
  • By Packaging Type, the Primary segment held the highest revenue share of 75.2% in 2023

Pharmaceutical Packaging Market Size, 2023 To 2032 (USD Billion)

AI (GPT) is here !!! Ask questions about Pharmaceutical Packaging Market
Loading....

Pharmaceutical Packaging Market: Regional Overview

North America dominated the Pharmaceutical Packaging market in 2023, with 36.5% of revenue share. This is because of a significant medical expenditure, technological advances and strict regulatory requirements. A number of packaging types, such as bottles, blister packs, vials, tubes and prefillable syringes, which are intended to meet the different needs of the medicine, are included in the market. Innovation in this sector is driven by factors such as growing demand for personalized medicine and the growth of biopharmaceuticals. The regulatory environment in the region, with agencies such as FDA, imposes stringent standards for ensuring product safety and integrity to encourage development of tamperproof, child resistant or sustainable packaging.

U.S. Pharmaceutical Packaging Market Overview

The Pharmaceutical Packaging market in the United States, with a valuation of USD 41.8 Billion in 2023, is projected to reach around USD 76.6 Billion by 2032. A significant Compound Annual Growth Rate (CAGR) of 7% from 2024 to 2032 is projected in this forecast. The U.S. Pharmaceutical Packaging market is a significant part of the North American segment, characterized by strict regulations, technological innovation, and high healthcare spending. Driven by regulatory compliance and a focus on patient safety, the U.S. market emphasizes tamper-evident and child-resistant packaging. The demand for sustainable and eco-friendly packaging solutions is also on the rise, reflecting broader environmental trends.

U.S. Pharmaceutical Packaging Market

The global Pharmaceutical Packaging market can be categorized as Type, Drug Delivery, Packaging Type, and Region.

Parameter Details
Segments Covered

By Type

  • Plastic Bottles
  • Blister Packs
  • Caps & Closures
  • Pre-filled Syringes
  • Pouches & Strips
  • Pre-filled Inhalers
  • Vials
  • Ampoules
  • Cartridges
  • Labels & Accessories
  • Medical Specialty Bags
  • Temperature-controlled Packaging
  • Medication Tubes
  • Jars & Canisters
  • Others

By Drug Delivery

  • Oral Drugs
  • Pulmonary
  • Transdermal
  • Injectables
  • Topical
  • Nasal
  • Ocular/Ophthalmic
  • IV Drugs
  • Others

By Packaging Type

  • Primary
  • Secondary

By Raw Material

  • Plastics
  • Paper & Paperboard
  • Glass
  • Metal
  • Others

By Region

  • North America
    • U.S.
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Amcor plc
  • Becton Dickinson and Company
  • AptarGroup Inc.
  • Berry Global Inc.
  • Gerresheimer AG
  • Schott AG
  • WestRock Company
  • SGD Pharma
  • Drug Plastics Group
  • O-I Glass Inc.
  • West Pharmaceutical Services Inc.
  • International Paper
  • Vetter Pharma International GmbH
  • Comar LLC
  • CCL Industries Inc.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Pharmaceutical Packaging Market: Type Overview

The Plastic Bottles segment dominated the type segment and accounted for over 24.4% of the total market revenue in 2023. Based on the Type, the Pharmaceutical Packaging market is segmented into Plastic Bottles, Blister Packs, Caps & Closures, Pre-filled Syringes, Pouches & Strips, Pre-filled Inhalers, Vials, Ampoules, Cartridges, Labels & Accessories, Medical Specialty Bags, Temperature-controlled Packaging, Medication Tubes, Jars & Canisters, and Others. The plastic bottles offer a lightweight, durable and cost effective solution for the storage of various medicines and health products. To ensure the integrity and safety of the pharmaceutical content, they provide excellent protection against moisture, contaminants and physical damage. In this segment, high-density polyethylene and polyethylene terephthalate are among the most common plastics used due to their strength and resistance to chemicals. For example, HDPE plastic bottles are widely used to package over-the-counter medications like ibuprofen, where the opaque nature of HDPE protects the medication from light exposure.

Pharmaceutical Packaging Market: Drug Delivery Overview

The Oral Drugs segment dominated the global Pharmaceutical Packaging market in 2023. Based on the Drug Delivery, the Pharmaceutical Packaging market is segmented into Oral Drugs, Pulmonary, Transdermal, Injectables, Topical, Nasal, Ocular/Ophthalmic, IV Drugs, and Others. The oral drugs segment in the Pharmaceutical Packaging market encompasses packaging solutions designed specifically for medications intended for oral administration, such as tablets, capsules, and liquids. This segment focuses on safety, tamper-evidence, and convenience to ensure medications are dispensed and consumed correctly. Blister packs and plastic bottles with child-resistant caps are common packaging types for oral drugs.

Pharmaceutical Packaging Market: Packaging Type Overview

In 2023, there was remarkable growth in the Primary segment, over 75.2% of the market share. Based on the Packaging Type, the Pharmaceutical Packaging market is divided into Primary and Secondary. The primary segment in the Pharmaceutical Packaging market refers to packaging materials that come into direct contact with pharmaceutical products. This part is crucial for ensuring the safety, stability and efficacy of the medicinal product which offers protection from contamination, moisture, light or any environment factor. Common examples of primary packaging include blister packs, bottles, vials, and pre-filled syringes. Glass vials used to package injectable medicinal products, vaccines and biologics are one of the most common examples. The glass vial is selected for its chemical inertness which makes it a safe barrier against drug interactions while being transparent that allows easy inspection. In order to maintain product safety and to comply with regulatory standards, this primary packaging form also supports sterile processing.

Pharmaceutical Packaging Market by Packaging Type 2023

Key Trends

  1. A growing concern about reducing the environmental impact is driving the development of biodegradable and recyclable packaging materials. Companies are exploring innovative packaging designs, which reduce waste and promote recycling.
  2. Smart packaging, e.g. RFID tags and QR codes, is on the rise. These technologies help to improve transparency in the supply chain and facilitate measures against counterfeiting.
  3. Stricter regulations globally require Pharmaceutical Packaging to meet higher standards for tamper-evidence, child resistance, and sterility. This is leading to innovations in packaging design to ensure compliance.
  4. The adoption of user-friendly packaging, such as blister packs and easy open bottles, is being driven by the focus to improve adherence among patients. This trend is particularly important for elderly patients and those with disabilities.
  5. Special packaging, such as prefilled syringes and vials for the preservation of product stability and sterility, is becoming increasingly important due to growing importance of biopharmaceuticals.

Premium Insights

In January 2023, Denmark, Germany, the Netherlands, Sweden, and Norway proposed a European Union-wide ban on a broad range of per- and polyfluoroalkyl substances (PFAS) under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation. This is an important step towards the regulation of these substances in the pharmaceutical sector. The proposed ban would target raw materials, excipients, and packaging but would not include active pharmaceutical ingredients (APIs). Monitoring the impact of this initiative on regulatory requirements for Chemistry, Manufacturing and Control (CMC) in relation to primary & secondary packaging will be essential.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

SCHOTT has initiated the production of amber pharma glass in India to meet growing market demand, marking a strategic effort to increase the availability of borosilicate glass for Pharmaceutical Packaging manufacturers in India and Asia. The company plans to invest EUR 75 million (approximately INR 660 crore) over three years to double its pharma tubing capacity in the region, creating 150 new jobs at its Gujarat-based facility. This plant is a production base for SCHOTT's glass tubes of borosilicate, high quality materials used in the manufacture of pharmaceutical containers such as vials, ampoules and syringes that contain lifesaving medicines. In support of Germany's commitment to increasing investments in India, this expansion is in line with the objective of the Indian Government to further establish India as a global pharmaceutical hub. Local production is expected to enhance availability, improve planning reliability, and reduce costs for pharmaceutical converters.

A range of more environmentally friendly Pharmaceutical Packaging solutions has been introduced by Amcor. In addition to its existing line of Pharmaceutical Packaging, this company introduces new High Shield laminates which are intended for better sustainability. These new packaging options comply with the stringent performance standards demanded by the industry, while at the same time meeting pharmaceutical companies' objectives of recyclable packaging in terms of their reduced carbon footprint and recycling. Various packaging formats such as sachets, stick packs and strips available in paper based Polyolefin materials offering flexibility to meet different needs are part of the High Shield innovations. In order to support pharmaceutical companies in their market differentiation efforts, the innovative structure of these laminates guarantees that they can be recycled as required by regional requirements. Furthermore, their compatibility with existing filling machines minimizes the need for additional investments or efficiency compromises for manufacturers and packers.

Competitive Landscape

Intense competition between different companies characterized the global market for packaging of pharmaceuticals, with a large number of competitors aiming to strengthen their position on the market. Existing and emerging participants, each with a view to meeting the evolving industry needs and regulatory requirements, form part of this competitive landscape. Investments in innovation, sustainability and advanced technology continue to give a strong foothold to major players such as Gerresheimer, Amcor or West Pharma Services. For example, Gerresheimer has opened a new facility in Berlin, Ohio, to manufacture pharmaceutical container solutions. The company officially inaugurated the building with a ceremony, and it will soon produce square plastic containers under the Duma Twist-Off Q brand. These 40-ml containers, designed with child-resistant closures and built-in desiccants, will be manufactured in a clean room to meet the needs of the North American market for medication packaging.

Recent Market Developments

  • In March 2024, SCHOTT Pharma is set to grow its presence in the U.S. with a new prefillable syringe production facility in Wilson, North Carolina. The $371 million investment will bring over 400 new jobs to the area. This facility will be the first in the U.S. to meet the demand for domestically produced glass and polymer prefillable syringes used for mRNA, GLP-1, and other therapeutic deliveries.
  • In February 2024, Aptar CSP Technologies, a division of AptarGroup, Inc. known for its active material science expertise, teamed up with ProAmpac, a leader in flexible packaging and material science, to create and launch ProActive Intelligence Moisture Protect (MP-1000). This innovative platform combines Aptar CSP's unique 3-Phase Activ-Polymer™ technology with ProAmpac's flexible blown film technology, resulting in a patent-pending moisture-absorbing flexible packaging solution.
  • In October 2023, Gerresheimer has teamed up with Rezemo to develop bio-based closures. This partnership focuses on creating innovative and sustainable closures for primary packaging solutions, catering to various industries such as cosmetics, food and beverages, and pharmaceuticals.
  • In August 2023, Amcor, a leading global company in responsible packaging solutions, has announced an agreement to acquire Phoenix Flexibles, thereby expanding its presence in the rapidly growing Indian market. Phoenix Flexibles, which operates a facility in Gujarat, India, generates around US$20 million annually from its flexible packaging products used in food, home care, and personal care. Additionally, the company is investing to double its local capacity in pharmaceutical and medical packaging sectors.
  • In February 2023, Gerresheimer introduced its new Clinical Trial Kit at Pharmapack in Paris. This kit includes sterile Gx RTF vials in a nest and tub or tray with corresponding closures, designed to meet the needs of new drug, vaccine, and biologics development during early phases. The Clinical Trial Kit is ideal for small-scale manufacturing, ranging from initial trials to validation and clinical batches.
  • In October 2023, SCHOTT AG has unveiled FIOLAX® Pro glass tubing, marking a new advancement in type I borosilicate glass tubing designed to cater to the evolving demands of the pharmaceutical industry. This latest product, along with its related services, is aimed at supporting three key industry trends: the growth of complex pharmaceuticals, sustainability efforts, and the adoption of digital technologies.

FAQ
Frequently Asked Question
  • The global Pharmaceutical Packaging valued at USD 143 Billion in 2023 and is expected to reach USD 500 Billion in 2032 growing at a CAGR of 15%.

  • The prominent players in the market are Amcor plc, Becton Dickinson and Company, AptarGroup Inc., Berry Global Inc., Gerresheimer AG, Schott AG, WestRock Company, SGD Pharma, Drug Plastics Group, O-I Glass Inc., West Pharmaceutical Services Inc., International Paper, Vetter Pharma International GmbH, Comar LLC, CCL Industries Inc..

  • The market is project to grow at a CAGR of 15% between 2024 and 2032.

  • The driving factors of the Pharmaceutical Packaging include

  • North America was the leading regional segment of the Pharmaceutical Packaging in 2023.